This study is not yet accepting patients
A Study of EP0031-101 in Patients With Advanced RET-altered Malignancies
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Ellipses Pharma
- ID
- NCT05443126
- Phase
- Phase 1/2 Solid Tumor Research Study
- Study Type
- Interventional
- Participants
- Expecting 265 study participants
- Last Updated